DopamineReceptors, Dopamine D2Receptors, Dopamine D1Dopamine AgonistsDopamine AntagonistsReceptors, DopamineReceptors, Dopamine D3Serotonin Uptake InhibitorsDopamine Plasma Membrane Transport ProteinsDopamine AgentsDopamine Uptake InhibitorsReceptors, Dopamine D5FluoxetineDopamine beta-HydroxylaseCitalopramAdrenergic Uptake InhibitorsCorpus StriatumParoxetineNeurotransmitter Uptake InhibitorsQuinpiroleBenzazepinesSerotoninAntidepressive AgentsNucleus AccumbensCocaineMicrodialysisRacloprideSulpirideAntidepressive Agents, Second-GenerationAntidepressive Agents, TricyclicRats, Sprague-DawleyFluvoxamineSerotonin Plasma Membrane Transport ProteinsNeostriatumLevodopaHaloperidolApomorphineAmphetamineSalicylamidesTyrosine 3-MonooxygenaseDopaminergic NeuronsBehavior, AnimalSertralineDesipramineHomovanillic AcidNorepinephrine Plasma Membrane Transport ProteinsBiogenic MonoaminesNorepinephrineVentral Tegmental AreaSubstantia NigraDopamine and cAMP-Regulated Phosphoprotein 32CyclohexanolsSpiperoneNomifensineOxidopamineMotor ActivityMesencephalonNeuronsDose-Response Relationship, DrugErgolinesalpha-MethyltyrosineBrainVesicular Monoamine Transport ProteinsTropanesClomipramineCaudate NucleusSerotonin AntagonistsDomperidonePropylaminesRewardDihydroxyphenylalanineDrug InteractionsMethamphetamineReceptors, SerotoninFlupenthixolPrefrontal CortexCentral Nervous System StimulantsBromocriptineAntipsychotic Agentsp-Chloroamphetamine8-Hydroxy-2-(di-n-propylamino)tetralinPutamenPiperazinesSerotonin Receptor AgonistsParkinsonian DisordersReserpineTyramineMonoamine Oxidase InhibitorsNerve Tissue ProteinsBrain ChemistrySynaptosomesCatecholaminesSynaptic TransmissionCyclobutanesButaclamolAutoreceptorsAnalysis of VarianceMethylphenidateMazindolSerotonin Agents